scholarly article | Q13442814 |
P356 | DOI | 10.1056/NEJM199410203311601 |
P698 | PubMed publication ID | 8090162 |
P50 | author | Christian W Hamm | Q66829316 |
P2093 | author name string | Berger J | |
Ischinger T | |||
Bleifeld W | |||
Rupprecht HJ | |||
Reimers J | |||
P433 | issue | 16 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | coronary artery bypass surgery | Q186020 |
angioplasty | Q539795 | ||
P304 | page(s) | 1037-1043 | |
P577 | publication date | 1994-10-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI) | |
P478 | volume | 331 |
Q71656874 | "Keyhole" coronary artery bypass surgery |
Q77958663 | A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty |
Q73298948 | A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes |
Q46200732 | A meta-analysis of randomized trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty in multivessel coronary artery disease |
Q45334693 | A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The AWESOME (Veterans Affairs Cooperative Study #385, angina with extremely serious operative mortality evaluation) in |
Q50939026 | A profile of candidates for repeat myocardial revascularization: implications for selection of treatment. |
Q33751623 | ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft [...] |
Q41609750 | Abrupt vessel closure: changing importance, management, and consequences |
Q42314599 | An Atelocollagen Coating for Efficient Local Gene Silencing by Using Small Interfering RNA |
Q39455494 | Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators |
Q70874571 | Angioplasty versus bypass surgery |
Q37221177 | Anti-inflammatory effect of abciximab-coated stent in a porcine coronary restenosis model |
Q33598940 | Appropriateness of referral of coronary angiography patients in Sweden. SECOR/SBU Project Group. |
Q29540554 | Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results |
Q73589268 | Assessing and reducing cardiac risks of noncardiac surgery |
Q48797738 | Assessment of quality of life with the Nottingham Health Profile among women with coronary artery disease |
Q44244533 | Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality |
Q73055212 | Association between new electrocardiographic abnormalities after coronary revascularization and five-year cardiac mortality in BARI randomized and registry patients |
Q35107657 | Beyond Complete Myocardial Revascularization: Is It Important and Does It Matter? |
Q43879544 | Bypass surgery versus percutaneous coronary intervention in patients with diabetes mellitus |
Q43917156 | Cardiac troponin I in perioperative myocardial infarction after coronary artery bypass surgery |
Q73370442 | Changes in immediate outcome of percutaneous transluminal coronary angioplasty in multivessel coronary artery disease in 1990 to 1991 versus 1994 to 1995 |
Q93719299 | Clinical Digest |
Q34002233 | Clinical and nonclinical correlates of racial and ethnic differences in recommendation patterns for coronary revascularization. |
Q56928575 | Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplasty |
Q47694677 | Clinical outcome after multivessel coronary stent implantation |
Q39388325 | Common cardiovascular issues encountered in geriatric critical care |
Q36351313 | Comparative effectiveness of revascularization strategies |
Q24603109 | Comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis |
Q40482642 | Coronary angioplasty versus bypass grafting: Cost-Benefit considerations |
Q39461430 | Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery |
Q33584436 | Coronary artery bypass surgery versus coronary stenting: risk-adjusted survival rates in 5,619 patients |
Q34154713 | Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial |
Q36824787 | Coronary artery revascularization evaluation--a multicenter registry with seven years of follow-up |
Q71566519 | Coronary revascularization: importance of observational data |
Q35580809 | Coronary stenting versus coronary bypass surgery in patients with multiple vessel disease and significant proximal LAD stenosis: results from the ERACI II study |
Q41099219 | Cost-effective management of chronic stable angina |
Q73038848 | Costs of revascularization over eight years in the randomized and eligible patients in the Emory Angioplasty versus Surgery Trial (EAST) |
Q38578862 | Critical analysis of coronary artery bypass graft surgery: a 30-year journey |
Q42058437 | Current incidence and determinants of perioperative myocardial infarction in coronary artery surgery |
Q52919584 | Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer. |
Q47624815 | Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission. |
Q40385431 | Description of a Heart Team approach to coronary revascularization and its beneficial long-term effect on clinical events after PCI. |
Q52193859 | Development of a minimally invasive technique for coronary revascularization in a porcine model. |
Q33781183 | Diagnosis and management of patients with unstable angina |
Q41668296 | Diagnosis of suspected coronary artery disease in women: a cost-effectiveness analysis |
Q73762917 | Differences in outcome between percutaneous coronary intervention and coronary bypass grafting |
Q77947101 | Early and midterm outcome after off-pump and on-pump surgery in Beating Heart Against Cardioplegic Arrest Studies (BHACAS 1 and 2): a pooled analysis of two randomised controlled trials |
Q44057486 | Economic benefits of amlodipine treatment in patients with coronary artery disease |
Q35048369 | Effect of a dual drug-coated stent with abciximab and alpha-lipoic Acid in a porcine coronary restenosis model |
Q39440226 | Effect of age in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial |
Q73746075 | Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty |
Q36826646 | Effect of the increasing use of coronary angioplasty on outcome at one year in patients with unstable angina |
Q44575008 | Effects of atorvastatin on in-stent stenosis in normo- and hypercholesterolemic rabbits |
Q50658760 | Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST) |
Q35230526 | Evaluation of clinical outcomes in patients undergoing dual vessel percutaneous coronary intervention using sirolimus-eluting coronary stent system in India. |
Q30655499 | Evaluation of the long-term functional outcome assessed by myocardial perfusion scintigraphy following excimer laser angioplasty compared to balloon angioplasty in longer coronary lesions |
Q36843409 | Factors affecting the therapeutic choice in patients with multivessel coronary artery disease. The Studio Lombardo Angiografia Multivasali (SLAM) Study Group |
Q34200070 | Health-related quality of life after percutaneous coronary intervention versus coronary bypass surgery in high-risk patients with medically refractory ischemia |
Q36441977 | How to revascularize patients with diabetes mellitus: bypass or stents and drugs? |
Q77108299 | Impact of postangioplasty restenosis on comparisons of outcome between angioplasty and bypass grafting. Coronary Angioplasty versus Bypass Revascularisation Investigation (CABRI) Investigators |
Q64954758 | Impact of routine angiographic follow-up after angioplasty. |
Q77808550 | Improving outcomes of percutaneous coronary intervention |
Q45210864 | Incidence and predictors of target vessel revascularization following percutaneous transluminal coronary angioplasty: a report from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry |
Q36840996 | Indications for coronary revascularisation: a Dutch perspective |
Q42058590 | Indications, practice, and procedural outcomes of percutaneous transluminal coronary angioplasty in northern New England in the early 1990s. The Northern New England Cardiovascular Disease Study Group |
Q40414973 | Internal medicine update: seven important advances in medical diagnosis and management for the general internist |
Q37810400 | Is Angioplasty Able to Become the Gold Standard of Treatment Beyond Bypass Surgery for Patients With Multivessel Coronary Artery Disease? - Therapeutic Strategies for 3-Vessel Coronary Artery Disease: OPCAB vs PCI (PCI-Side) - |
Q58976215 | Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? |
Q43016772 | Is surgery still the preferred option for coronary revascularisation in diabetics with multivessel coronary disease? |
Q73857137 | Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation |
Q74360924 | Long-term follow-up after deferring angioplasty in asymptomatic patients with moderate noncritical in-stent restenosis |
Q51030505 | Long-term results after successful percutaneous transluminal coronary angioplasty in patients over 75 years of age. |
Q77530104 | Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina |
Q50611420 | Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. |
Q33671970 | Management of high-risk subsets in unstable angina |
Q77522059 | Medical therapies for the prevention of restenosis after percutaneous coronary interventions |
Q39361157 | Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery |
Q34068731 | Mid-term outcomes of patients with PCI prior to CABG in comparison to patients with primary CABG. |
Q43070774 | Minimally invasive direct coronary artery bypass: anesthetic, monitoring, and pain control considerations |
Q78251182 | Multivariate prediction of in-hospital mortality after percutaneous coronary interventions in 1994-1996. Northern New England Cardiovascular Disease Study Group |
Q73476786 | Multivessel Palmaz-Schatz stenting: early results and one-year outcome |
Q73599582 | Multivessel coronary stenting versus bypass surgery in patients with multivessel coronary artery disease and normal left ventricular function: immediate and 2-year long-term follow-up |
Q78043417 | Myocardial revascularization in patients with end-stage renal disease: comparison of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting |
Q34306764 | New developments in percutaneous coronary intervention |
Q35582564 | One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial |
Q50960493 | Outcome > or = 10 years after successful percutaneous transluminal coronary angioplasty. |
Q35379466 | Outcomes following coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in the stent era: a prospective study of all 9890 consecutive patients operated on in Scotland over a two year period. |
Q38574815 | Outcomes of Coronary Artery Bypass Graft Surgery in 24 461 Patients Aged 80 Years or Older |
Q37101866 | Outcomes of revascularization strategies for two-vessel coronary artery disease involving the proximal left anterior descending artery in an era of improved pharmacotherapy and stenting |
Q71525826 | PTCA with the use of cardiac assist devices: risk stratification, short- and long-term results |
Q40874951 | Pathophysiology and treatment of single-vessel coronary artery disease |
Q43408475 | Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Depart |
Q28174081 | Percutaneous coronary intervention versus coronary artery bypass grafting for diabetics with multivessel coronary artery disease: the Korean Multicenter Revascularization Registry (KORR) |
Q78503399 | Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry |
Q77480625 | Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized |
Q74652716 | Percutaneous intervention in the very elderly: weighing the risks and benefits |
Q71525831 | Percutaneous transluminal angioplasty of internal mammary arteries in patients with rest angina |
Q38068350 | Percutaneous versus surgical interventions for coronary artery disease in those with diabetes mellitus |
Q51661902 | Poor functional recovery may indicate restenosis in patients after coronary angioplasty. |
Q36795869 | Port-access coronary artery bypass grafting: a proposed surgical method. |
Q50944798 | Predictors of CABG within one year of successful PTCA: a retrospective, case-control study. |
Q73386952 | Present-day PTCR versus CABG: a randomized comparison with a different focus and a new result |
Q73742260 | Pro: Preoperative thallium testing should be routinely performed before vascular surgery |
Q73277479 | Pro: Standard percutaneous coronary intervention is the procedure of choice for myocardial revascularization |
Q78108703 | Procedural results and late clinical outcomes following multivessel coronary stenting |
Q44170672 | Prognostic value of thallium-201 single-photon emission computed tomography for patients with multivessel coronary artery disease after revascularization (the Emory Angioplasty versus Surgery Trial [EAST]). |
Q53536553 | Quality of life comparisons after coronary angioplasty and coronary artery bypass graft surgery. |
Q34746648 | Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease |
Q39711593 | Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease |
Q73128785 | Relation between coronary artery disease, baseline clinical variables, revascularization mode, and mortality. CABRI Participants. Coronary Angioplasty vs. Bypass Revascularisation Investigation |
Q73456997 | Relation of unstable angina and myocardial infarction to progression of coronary narrowing in patients undergoing coronary artery bypass grafting (utilizing an internal mammary artery) |
Q73218068 | Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI) |
Q36486769 | Restenosis related to percutaneous coronary intervention has been solved? |
Q40941250 | Restenosis--an open file |
Q78060195 | Results (>6 months) of stenting of >1 major coronary artery in multivessel coronary artery disease |
Q78106208 | Retrieval and analysis of particulate debris after saphenous vein graft intervention |
Q35862852 | Revascularisation in diabetics with multivessel coronary artery disease |
Q38013670 | Revascularization for left main and multivessel coronary artery disease in the drug-eluting stent era: integration of recent drug-eluting stent trials |
Q32064291 | Revascularization in coronary artery disease. A review of randomized trial data |
Q35655575 | Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty |
Q40979083 | Roles of percutaneous transluminal coronary angioplasty and bypass graft surgery for the treatment of coronary artery disease |
Q71986364 | Safety and efficacy of concomitant carotid and coronary artery operations |
Q73739650 | Self-rated health and clinical status after PTCA: results of a 4-year follow-up in 500 patients |
Q36873754 | Single and multivessel port-access coronary artery bypass grafting with cardioplegic arrest: technique and reproducibility. |
Q73308493 | Succesful Identification and Management of High-Risk Patients with Acute Myocardial Infarction |
Q74776334 | Surgery on trial: an account of clinical trials evaluating operations |
Q78383928 | Surgery or stent? The gap continues to narrow |
Q38262668 | Surgical versus percutaneous revascularization in patients with multivessel coronary artery disease |
Q28199121 | Surgical, medical, and percutaneous therapies for patients with multivessel coronary artery disease |
Q58975582 | Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy |
Q46182070 | Temporal gene expression analysis of human coronary artery endothelial cells treated with Simvastatin. |
Q38248174 | The 100 most cited publications in cardiac surgery: a bibliometric analysis |
Q39470269 | The Medicine, Angioplasty or Surgery Study (MASS): A prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses |
Q42393327 | The case for concomitant carotid and coronary artery surgery |
Q34746674 | The development of interventional cardiology |
Q73447957 | The effect of adjusting for baseline risk factors and post revascularisation coronary disease on comparisons between coronary angioplasty and bypass surgery |
Q34534765 | The effect of completeness of revascularization on event-free survival at one year in the ARTS trial |
Q36647241 | The impact of performing a clinical trial on patient outcomes: lessons from the Emory Angioplasty vs. Surgery Trial |
Q33703009 | The invasive management of angina: issues for consumers and commissioners |
Q30850777 | The practical clinical guidelines of the Sociedad Española de Cardiología on interventional cardiology: coronary angioplasty and other technics |
Q52168321 | The revival of surgical treatment for isolated proximal high grade LAD lesions by minimally invasive coronary artery bypass grafting. |
Q44630310 | The role of myocardial revascularization preceding noncardiac surgery |
Q52243494 | The role of the cardiology consultant: putting it all together. |
Q71907120 | Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries |
Q73467232 | Transient ventricular asystole using adenosine during minimally invasive and open sternotomy coronary artery bypass grafting |
Q33699764 | Treatment of Stable Angina Pectoris |
Q35582798 | Trends in two year risk of repeat revascularisation or death from cardiovascular disease after coronary artery bypass grafting or percutaneous coronary intervention in Western Australia, 1980-2001 |
Q45334905 | Two- to three-year follow-up of patients with single-vessel coronary artery disease randomized to PTCA or medical therapy (results of a VA cooperative study). Veterans Affairs Cooperative Studies Program ACME Investigators. Angioplasty Compared to M |
Q38558645 | Understanding the Outcome of Randomized Trials with Drug-Eluting Stents and Coronary Artery Bypass Graft in Patients with Multivessel Disease: A Review of a 25-Year Journey |
Q71566501 | Use of coronary artery bypass surgical procedure and coronary angioplasty in treatment of coronary artery disease: changes during a 10-year period at Mayo Clinic Rochester |
Q40873889 | Utility of stress single-photon emission computed tomography (SPECT) perfusion imaging in predicting outcome after coronary artery bypass grafting |
Q77892303 | [Arterial myocardial revascularization in the 9th decade of life. Personal results and review of the literature] |
Q74319612 | [Comparison between PTCA and bypass operation. Results of large randomized studies] |
Q78493362 | [Coronary angioplasty in diabetic patients. Current and future perspectives] |
Q73587538 | [The practical clinical guidelines of the Sociedad Española de Cardiología on coronary surgery] |
Search more.